Sheila Jacobs

Most Recent Articles by Sheila Jacobs

Clinical Features Identified in Enthesitis-Related Juvenile Idiopathic Arthritis, Juvenile Spondyloarthritis

Clinical Features Identified in Enthesitis-Related Juvenile Idiopathic Arthritis, Juvenile Spondyloarthritis

By

Results confirm that juvenile spondyloarthritis is characterized by its peripheral pattern at disease onset, with peripheral arthritis and enthesitis.

Quality of SLE Care Assessed in Specialized Lupus vs General Rheumatology Clinic

Quality of SLE Care Assessed in Specialized Lupus vs General Rheumatology Clinic

By

Researchers compared the quality of care received by patients with systemic lupus erythematosus in 2 settings within the same academic institution.

Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis

Etanercept Monotherapy vs Combination Therapy Examined in Psoriatic Arthritis

By

Etanercept in combination with a conventional synthetic DMARD did not substantially improve clinical response compared with etanercept monotherapy in patients with psoriatic arthritis.

Dual Neutralization of IL-17A, IL-17F With Bimekizumab Suppresses PsA Joint Inflammation

Dual Neutralization of IL-17A, IL-17F With Bimekizumab Suppresses PsA Joint Inflammation

By

Dual inhibition of IL-17A and IL-17F with bimekizumab suppresses joint inflammation in patients with psoriatic arthritis.

Sirukumab Effective in Rheumatoid Arthritis Refractory to Methotrexate or Sulfasalazine

Sirukumab Effective in Rheumatoid Arthritis Refractory to Methotrexate or Sulfasalazine

By

In patients with rheumatoid arthritis refractory to methotrexate and sulfasalazine, sirukumab monotherapy is generally tolerable with measurable efficacy over the course of 52 weeks.

More Articles by Sheila Jacobs

Sign Up for Free e-newsletters